These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10589948)

  • 1. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C--clinical and virologic implications.
    Dickson RC; Mizokami M; Orito E; Qian KP; Lau JY
    Transplantation; 1999 Nov; 68(10):1512-6. PubMed ID: 10589948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
    J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia.
    Tanaka T; Lau JY; Mizokami M; Orito E; Tanaka E; Kiyosawa K; Yasui K; Ohta Y; Hasegawa A; Tanaka S
    J Hepatol; 1995 Dec; 23(6):742-5. PubMed ID: 8750176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
    Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
    J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of hepatitis C virus core antigen immunoassay in monitoring viral load after liver transplantation.
    Massaguer A; Forns X; Costa J; Feliu A; García-Retortillo M; Navasa M; Rimola A; García-Valdecasas JC; Sánchez-Tapias JM
    Transplantation; 2005 May; 79(10):1441-4. PubMed ID: 15912117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.
    Lagging LM; Garcia CE; Westin J; Wejstål R; Norkrans G; Dhillon AP; Lindh M
    J Clin Microbiol; 2002 Nov; 40(11):4224-9. PubMed ID: 12409402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.
    Medici MC; Furlini G; Rodella A; Fuertes A; Monachetti A; Calderaro A; Galli S; Terlenghi L; Olivares M; Bagnarelli P; Costantini A; De Conto F; Sainz M; Galli C; Manca N; Landini MP; Dettori G; Chezzi C
    J Clin Virol; 2011 Aug; 51(4):264-9. PubMed ID: 21621454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total HCV core antigen assay. A new marker of HCV viremia and its application during treatment of chronic hepatitis C.
    Lorenzo J; Castro A; Aguilera A; Prieto E; López-Calvo S; Regueiro B; Pedreira J
    J Virol Methods; 2004 Sep; 120(2):173-7. PubMed ID: 15288960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes.
    Orito E; Mizokami M; Tanaka T; Lau JY; Suzuki K; Yamauchi M; Ohta Y; Hasegawa A; Tanaka S; Kohara M
    Gut; 1996 Dec; 39(6):876-80. PubMed ID: 9038674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core antigen testing in liver and kidney transplant recipients.
    Heidrich B; Pischke S; Helfritz FA; Mederacke I; Kirschner J; Schneider J; Raupach R; Jäckel E; Barg-Hock H; Lehner F; Klempnauer J; von Hahn T; Cornberg M; Manns MP; Ciesek S; Wedemeyer H
    J Viral Hepat; 2014 Nov; 21(11):769-79. PubMed ID: 24251818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients.
    Fabrizi F; Lunghi G; Aucella F; Mangano S; Barbisoni F; Bisegna S; Vigilante D; Limido A; Martin P
    J Clin Microbiol; 2005 Jan; 43(1):414-20. PubMed ID: 15635003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.